NCT04088851View on ClinicalTrials.gov

"Hepatic Substrate Flux Rates in Type 2 Diabetes"

NAActive, not recruitingINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

September 11, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Type 2 Diabetes
Interventions
DRUG

On Metformin

Oral intake of Metformin (1 g / day) for 2 weeks

DRUG

Off Metformin

No oral intake of Metformin (1 g / day) for 2 weeks

Trial Locations (1)

40225

German Diabetes Center, Düsseldorf

Sponsors
All Listed Sponsors
collaborator

Yale University

OTHER

lead

German Diabetes Center

OTHER

NCT04088851 - "Hepatic Substrate Flux Rates in Type 2 Diabetes" | Biotech Hunter | Biotech Hunter